Onderneming Pediatrx Inc OTC Bulletin Board
Aandelen
US70532X1072
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
|
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biopharma Services
76,7
%
| - | - | 0 | 76,7 % | - |
Patient Testing Service
23,3
%
| - | - | 0 | 23,3 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +6,85% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Director of Finance/CFO | 43 | 01-01-09 | |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 01-01-18 |
Trevor McCartney
IRO | Public Communications Contact | - | 01-03-19 |
Michael Vallone
PRN | Corporate Officer/Principal | - | 09-01-23 |
Mattia Cremona
PRN | Corporate Officer/Principal | - | 07-11-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 18-06-20 |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 01-01-18 |
Director of Finance/CFO | 43 | 01-01-09 | |
Danica Holley
BRD | Director/Board Member | 51 | 04-04-22 |
Yvonne Fors
BRD | Director/Board Member | 52 | 18-06-20 |
Matthew Schwartz
BRD | Director/Board Member | 50 | 05-04-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 500 | 0 | 0 | 17,39 % |
Aandeel B | 0 | 1 000 | 0 | 0 | |
Aandeel C | 1 | 6 151 499 919 | 1 069 660 735 ( 17,39 %) | 0 |
Bedrijfsgegevens
![Adres Pediatrx Inc](https://cdn.zonebourse.com/static/address/7091946.png)
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,62% | 127 mld. | |
+24,76% | 117 mld. | |
+25,44% | 27,67 mld. | |
-17,99% | 20,33 mld. | |
-15,17% | 16,79 mld. | |
-14,68% | 15,63 mld. | |
+12,81% | 14,84 mld. | |
-47,10% | 14,65 mld. | |
+56,21% | 14,43 mld. |
- Beurs
- Aandelen
- Koers THER
- Koers
- Onderneming Pediatrx Inc